FILE PHOTO: A vial of Botox, owned by AbbVie, is seen next to its packaging in a photo illustration in Manhattan, New York, U.S., December 8, 2021. REUTERS/Andrew Kelly/File Photo
FILE PHOTO: A vial of Botox, owned by AbbVie, is seen next to its packaging in a photo illustration in Manhattan, New York, U.S., December 8, 2021. REUTERS/Andrew Kelly/File Photo